Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Thiazolidinediones Tied to Lower Cancer Risk in Diabetes Patients
Pioglitazone, rosiglitazone linked to lower liver cancer risk; rosiglitazone tied to lower CRC risk
This article is older than one year and is no longer available.

Copyright © 2012 HealthDay. All rights reserved.

September 30, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

'Just-in-Time' Methodology Can Reduce Patient Waiting Times

AACR: Obese in Adolescence, Colon Cancer in Later Life?

AMA Launches Three Programs for Physician Wellness

Insulin Increases Resting-State Functional Connectivity in T2DM

ESMO: Drug Gives Survival Boost in HER2+ Breast Cancer

ESMO: Combo Treatments Up Survival in Metastatic Melanoma